CBIO vs ES · $491.3M cap vs P/E 28, rev $11.90B
Crescent Biopharma, Inc. (CBIO) versus Eversource Energy (ES) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Eversource Energy (ES) is a utilities - regulated electric company listed on US.
CBIO does not have a complete income-statement cache yet.
Latest reported ES revenue for 2024-12-31 was $11.90B. Net income was $819.2M. Revenue was down 0.1% from 2023-12-31 to 2024-12-31. ES currently screens at market cap $23.72B and trailing P/E 28.3.
CBIO currently screens at market cap $491.3M. ES currently screens at market cap $23.72B and trailing P/E 28.3.
Not investment advice. Open the CBIO and ES stock pages for the full models.
Not investment advice.